TABL~ I

Description of Cell Lines Used in Thzs Paper
Embryos. The procedures for the preparation and the immunolabeling of preimplantation embryos were essentially as described elsewhere (7) . Blastocyst inner cell masses were isolated following the technique of Solter and Knowles (23) . Most of the embryos used here were produced by hormonally primed 4-to 5-wk-old 129/Sv mice mated with syngeneic males. Embryos from spontaneously ovulated females were used occasionally and gave identical results.
Fractionation of lmmunoglobulins. IgM, IgG1, and IgG2a,b antibodies were separated by affinity chromatograhy through a column of Protein-A sepharose (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.), following Ey et al. procedure (6) . Briefly, 1 ml of serum was mixed with 1 ml of 0.1 M phosphate buffer, pH 8.0, and adjusted to pH 8.0. This mixture was then applied onto a column of Protein-A-Sepharose (3 ml) preequilibrated with 0.1 M phosphate buffer, pH 8.0. The column was washed with the same buffer and the effluent (referred below as IgM) collected. The column was then washed with several volumes of citrate buffer 0.1 M, pH 6.0; the eluted material (IgG1) was saved. After extensive washing with the same buffer, pH 5.6, the still bound IgG2a and IgG2h were eluted simultaneously with citrate buffer pH 3.0, 0.1 M. The effluent was saved and is referred to below as IgG2a,b. The three fractions were neutralized, concentrated through an Amicon PM 10 membrane (Amicon Coo., Scientific Systems Div., Lexington, Mass.), adjusted to 4% fetal calf serum (FCS), and dialyzed overnight against 100 vol of phosphate-buffered saline (PBS). The separated Ig were stored at -78°C as aliquots. To be able to compare the various preparations used, the volume of each fraction is referred to a dilution of the unfractionated serum, i.e., when 8 ml of IgM are recovered from 1 ml of crude serum, the IgM preparation is taken as diluted 1/8.
The purity of each fraction was checked by double diffusion of the separated Ig (~ 1 mg/ml) against antibodies raised against purified myeloma proteins (5). Material unbound at pH 8.0 contained IgM and no contaminating IgG. Because IgA and IgE antibodies are essentially unreactive onto F9 cells (5), IgM were not further purified. Material eluted at pH 6.0 reacted only with anti-yl chain sera. Material eluted at pH 3.0 reacted with both anti-y2, and anti-y2b chains sera, but contained trace amounts of material reacting with anti-y1 chain serum.
Immunofluorescence Test. All experiments were conducted on suspensions of living cells using the double sandwich technique (22) . Washed cells (10 s) were suspended in 50/d of immunoglobulin at the appropriate dilution. After 45 min at 4°C, the unbound Ig were removed by three washings with Dulbecco's modified Eagle's medium (DMEM) containing 4% FCS. The washed cells were suspended in a 1/25 dilution of RAMIg-FITC and incubated for 30 min at 4°C. The cells were then washed three times in DMEM + 4% FCS and examined under a Zeiss epi-illumination fluorescent microscope (Carl Zeiss, Inc., New York). Controls, using Ig prepared from normal mouse serum or anti-F9 Ig absorbed with F9 cells, were run in parallel. The fraction of labeled cells, out of a total of 200 cells examined, was noted. The intensity of the immunostaining was scored from 0, no labeling to +++, very intense labeling.
The immunofluorescence test on preimplantation embryos was performed as described previously (7).
Cytotoxicity Test. The cytotoxicity test on F9 cells was performed according to published procedures (1).
Results
Activity of IgM, IgGl, and IgG2a,b Anti-F9 Antibodies on F9 Emb~yonal Carcinoma Cells.
Fractions containing various classes or subclasses of immunoglobulins were prepared from anti-F9 sera, and serotyped as described in Materials and Methods. They proved to have the following properties: (a) The IgM-containing fraction had retained cytotoxic activity: 80-100% F9 cells could be killed; the cytotoxic titer was 1/2,000-1/2,400 (compared with, 1/2,000- Controls were run with IgM, IgG1, and IgG2a,b antibodies prepared from normal mouse serum. These had no activity on F9 cells in either test, at the lowest dilutions used (1/10, 1/3, and 1/3, respectively). Table II . At the 1/64 dilution, all E.C. lines were found to react strongly with IgM anti-F9 antibodies. The percentage of positive cells, however, varies widely according to the lines, some of them (PCC4-azaR1 and Tera 1, a human teratoma line) (13) , showing only 15% of labeled cells. The labeling is easily detectable even at high dilutions (1/128 and 1/256), especially on cells from three lines, F9, PSA-1, and LT1 (a female teratoma line) (11) , which thus appear to be the lines displaying the largest amount of IgM binding-antigens.
Activity of IgM
In contrast, anti-F9 IgM antibodies, used at the same 1/64 dilution, did not react with differentiated cells. At a lower dilution (1/32), a few positive cells (1-15%) could be observed in several cell types with a variable staining (+ to +++). The meaning of this positive response, however, is questionable; for instance, absorption of IgM anti-F9 antibodies with PYS-2 cells (diluted 1/16, vol:vol, 1 h, 4°C) did not result in Activity of IgM, IgG1, and IgG2a, b Antibodies on Preimplantation Embryos. The normal counterpart of embryonal carcinoma cells is to be found in the multipotential cells of the early embryos (25) . The F9 antigens have been found on early embryonic cells, and their expression during development is well documented (1, 4, 26, 27) . The way in which the receptors of the main components of the anti-F9 serum are expressed during early embryogenesis has therefore been investigated. The results obtained are summarized in Table III .
IgM anti-F9 antibodies reacted strongly with embryos throughout their entire preimplantation development. Negative controls were run using IgM anti-F9 antibodies absorbed with F9 cells. These did not stain the embryos, irrespective of their developmental stage. Unabsorbed IgM antibodies, however, strongly stained the unfertilized ovocytes at the 1/64 dilution. The staining of embryos persisted until they reached the late morula stage. Later in development, trophectoderm cells had much less affinity for IgM anti-F9 antibodies, whereas inner cell mass cells retained the capacity to bind anti-F9 IgM.
IgG1 anti-F9 antibodies were never found to react with any cell at any stage, at any dilution of the reagent (lowest 1/2.5).
IgG2a,b anti-F9 antibodies, diluted 1/6, did not detect specific antigens on very early (one and two cell stages) preimplantation embryos. Between two and four cell stages, however, receptors begin to be expressed, which peak at the morula stage and disappear upon blastocyst formation. At this stage, these receptors are not detectable on trophectoderm cells or inner cell mass cells.
Earlier studies dealing with the expression of F9 antigens on preimplantation It may be pointed out that F9 antigens recovered after precipitation of E.C. cell extracts with anti-F9 serum (and especially with anti-F9 IgM antibodies, data not shown) contain long saccharidic chains characteristic of early embryonic cells (31) . On the other hand, the main target of IgM anti-F9 antibodies have been shown recently to be saccharidic residues (32) . The absence of polymorphism of F9 antigens, which has been observed so far among various mouse inbred su:ains as well as among mammalian species (4), might thus reflect the preservation of these saccharidic structures.
Moreover, F9 antigens have been found to bear some relationship with t wa2 and t "5 haplotypes of the T locus (7, 33) . This conclusion has been drawn from studies in which IgM receptors were looked at predominantly. One might then speculate that the cell surface components altered in t wa2 and t w5 homozygotes are saccharidic chains; some products of the T locus would, thus, be somehow related to carbohydrate metabolism of the embryos, a contention supported by recent evidence brought by Cheng and Bennett (34) .
Summary
Using an affinity chromatography technique, IgM, IgG1, and IgG2a,b anti-F9 antibodies have been isolated from the anti-F9 serum; their activities have been analyzed by IF test on a variety of cell types, teratocarcinoma-derived cell lines, and embryos. The anti-F9 antibodies react with at least three independent antigenic determinants not expressed on the same cell types, and that appear along different time-course during embryonic development.
